0001209191-24-001253.txt : 20240109
0001209191-24-001253.hdr.sgml : 20240109
20240109165620
ACCESSION NUMBER: 0001209191-24-001253
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240107
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mordwinkin Nicholas Michael
CENTRAL INDEX KEY: 0001937229
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 24523913
MAIL ADDRESS:
STREET 1: C/O KEZAR LIFE SCIENCES, INC.
STREET 2: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-07
0
0001645666
Kezar Life Sciences, Inc.
KZR
0001937229
Mordwinkin Nicholas Michael
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Business Officer
0
Employee Stock Option (right to buy)
0.93
2024-01-07
4
A
0
275000
0.00
A
2034-01-06
Common Stock
275000
275000
D
One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 7, 2024, subject to the Reporting Person continuing to provide service through each such date.
/s/ Marc Belsky, Attorney-in-Fact
2024-01-09